ALNYLAM PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 117.08 million shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-04-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-04-29
- ALNYLAM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 117.08M shares, a 3.84% increase year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 116.27M shares, a 4.05% increase year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 115.99M shares, a 6.70% increase year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 114.91M shares, a 5.83% increase year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 114.99M shares, a 5.24% increase from fiscal 2019.
- ALNYLAM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 109.26M shares, a 8.62% increase from fiscal 2018.
- ALNYLAM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 100.59M shares, a 11.08% increase from fiscal 2017.
- ALNYLAM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 90.55M shares, a 5.79% increase from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | 117.08M shares 10-Q · filed 2021-04-29 | 116.68M shares derived: average of 2 quarters · filed 2021-04-29 | 116.45M shares derived: average of 3 quarters · filed 2021-04-29 | 116.06M shares derived: average of 4 quarters · filed 2021-04-29 |
| 2020-12-31 | 116.27M shares 10-K · filed 2021-02-11 | 116.13M shares derived: average of 2 quarters · filed 2021-02-11 | 115.72M shares derived: average of 3 quarters · filed 2021-02-11 | 114.99M shares 10-K · filed 2021-02-11 |
| 2020-09-30 | 115.99M shares 10-K · filed 2021-02-11 | 115.45M shares derived: average of 2 quarters · filed 2021-02-11 | 114.55M shares 10-Q · filed 2020-11-05 | 113.85M shares derived: average of 4 quarters · filed 2021-04-29 |
| 2020-06-30 | 114.91M shares 10-K · filed 2021-02-11 | 113.83M shares 10-Q · filed 2020-08-06 | 113.14M shares derived: average of 3 quarters · filed 2021-04-29 | 112.03M shares derived: average of 4 quarters · filed 2021-04-29 |
| 2020-03-31 | 112.75M shares 10-Q · filed 2021-04-29 | 112.25M shares derived: average of 2 quarters · filed 2021-04-29 | 111.07M shares derived: average of 3 quarters · filed 2021-04-29 | 110.44M shares derived: average of 4 quarters · filed 2021-04-29 |
| 2019-12-31 | 111.75M shares 10-K · filed 2021-02-11 | 110.23M shares derived: average of 2 quarters · filed 2021-02-11 | 109.68M shares derived: average of 3 quarters · filed 2021-02-11 | 109.26M shares 10-K · filed 2021-02-11 |
| 2019-09-30 | 108.70M shares 10-K · filed 2021-02-11 | 108.64M shares derived: average of 2 quarters · filed 2021-02-11 | 108.43M shares 10-Q · filed 2020-11-05 | 105.94M shares derived: average of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | 108.58M shares 10-K · filed 2021-02-11 | 107.00M shares 10-Q · filed 2020-08-06 | 105.01M shares derived: average of 3 quarters · filed 2021-02-11 | 103.96M shares derived: average of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | 105.40M shares 10-K · filed 2021-02-11 | 103.23M shares derived: average of 2 quarters · filed 2021-02-11 | 102.42M shares derived: average of 3 quarters · filed 2021-02-11 | 101.94M shares derived: average of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | 101.07M shares 10-K · filed 2020-02-13 | 100.92M shares derived: average of 2 quarters · filed 2020-02-13 | 100.79M shares derived: average of 3 quarters · filed 2020-02-13 | 100.59M shares 10-K · filed 2021-02-11 |
| 2018-09-30 | 100.78M shares 10-K · filed 2020-02-13 | 100.65M shares derived: average of 2 quarters · filed 2020-02-13 | 100.43M shares 10-Q · filed 2019-10-31 | 99.36M shares derived: average of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | 100.52M shares 10-K · filed 2020-02-13 | 100.25M shares 10-Q · filed 2019-08-06 | 98.88M shares derived: average of 3 quarters · filed 2020-02-13 | 97.12M shares derived: average of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | 99.98M shares 10-K · filed 2020-02-13 | 98.06M shares derived: average of 2 quarters · filed 2020-02-13 | 95.98M shares derived: average of 3 quarters · filed 2020-02-13 | 94.01M shares derived: average of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | 96.14M shares 10-K · filed 2019-02-14 | 93.98M shares derived: average of 2 quarters · filed 2019-02-14 | 92.02M shares derived: average of 3 quarters · filed 2019-02-14 | 90.55M shares 10-K · filed 2020-02-13 |
| 2017-09-30 | 91.83M shares 10-K · filed 2019-02-14 | 89.96M shares derived: average of 2 quarters · filed 2019-02-14 | 88.67M shares 10-Q · filed 2018-11-07 | 87.95M shares derived: average of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | 88.10M shares 10-K · filed 2019-02-14 | 87.07M shares 10-Q · filed 2018-08-02 | 86.66M shares derived: average of 3 quarters · filed 2019-02-14 | 86.42M shares derived: average of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | 86.03M shares 10-K · filed 2019-02-14 | 85.94M shares derived: average of 2 quarters · filed 2019-02-14 | 85.86M shares derived: average of 3 quarters · filed 2019-02-14 | 85.78M shares derived: average of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | 85.84M shares 10-K · filed 2018-02-15 | 85.78M shares derived: average of 2 quarters · filed 2018-02-15 | 85.70M shares derived: average of 3 quarters · filed 2018-02-15 | 85.60M shares 10-K · filed 2019-02-14 |
| 2016-09-30 | 85.72M shares 10-K · filed 2018-02-15 | 85.63M shares derived: average of 2 quarters · filed 2018-02-15 | 85.51M shares 10-Q · filed 2017-11-07 | 85.35M shares derived: average of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | 85.55M shares 10-K · filed 2018-02-15 | 85.41M shares 10-Q · filed 2017-08-09 | 85.23M shares derived: average of 3 quarters · filed 2018-02-15 | 85.08M shares derived: average of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | 85.28M shares 10-K · filed 2018-02-15 | 85.07M shares derived: average of 2 quarters · filed 2018-02-15 | 84.93M shares derived: average of 3 quarters · filed 2018-02-15 | 84.78M shares derived: average of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | 84.87M shares 10-K · filed 2017-02-15 | 84.75M shares derived: average of 2 quarters · filed 2017-02-15 | 84.62M shares derived: average of 3 quarters · filed 2017-02-15 | 83.99M shares 10-K · filed 2018-02-15 |
| 2015-09-30 | 84.63M shares 10-K · filed 2017-02-15 | 84.49M shares derived: average of 2 quarters · filed 2017-02-15 | 83.70M shares 10-Q · filed 2016-11-03 | 82.00M shares derived: average of 4 quarters · filed 2017-02-15 |
| 2015-06-30 | 84.35M shares 10-K · filed 2017-02-15 | 83.22M shares 10-Q · filed 2016-08-04 | 81.13M shares derived: average of 3 quarters · filed 2017-02-15 | 79.95M shares derived: average of 4 quarters · filed 2017-02-15 |
| 2015-03-31 | 82.07M shares 10-K · filed 2017-02-15 | 79.52M shares derived: average of 2 quarters · filed 2017-02-15 | 78.48M shares derived: average of 3 quarters · filed 2017-02-15 | 77.82M shares derived: average of 4 quarters · filed 2017-02-15 |
| 2014-12-31 | 76.96M shares 10-K · filed 2016-02-12 | 76.68M shares derived: average of 2 quarters · filed 2016-02-12 | 76.40M shares derived: average of 3 quarters · filed 2016-02-12 | 74.28M shares 10-K · filed 2017-02-15 |
| 2014-09-30 | 76.41M shares 10-K · filed 2016-02-12 | 76.12M shares derived: average of 2 quarters · filed 2016-02-12 | 73.38M shares 10-Q · filed 2015-11-09 | 70.73M shares derived: average of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | 75.83M shares 10-K · filed 2016-02-12 | 71.83M shares 10-Q · filed 2015-08-07 | 68.84M shares derived: average of 3 quarters · filed 2016-02-12 | 67.24M shares derived: average of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | 67.79M shares 10-K · filed 2016-02-12 | 65.35M shares derived: average of 2 quarters · filed 2016-02-12 | 64.37M shares derived: average of 3 quarters · filed 2016-02-12 | 63.69M shares derived: average of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | 62.91M shares 10-K · filed 2015-02-13 | 62.66M shares derived: average of 2 quarters · filed 2015-02-13 | 62.33M shares derived: average of 3 quarters · filed 2015-02-13 | 61.55M shares 10-K · filed 2016-02-12 |
| 2013-09-30 | 62.42M shares 10-K · filed 2015-02-13 | 62.04M shares derived: average of 2 quarters · filed 2015-02-13 | 61.10M shares 10-Q · filed 2014-11-06 | 58.77M shares derived: average of 4 quarters · filed 2015-02-13 |
| 2013-06-30 | 61.66M shares 10-K · filed 2015-02-13 | 60.42M shares 10-Q · filed 2014-08-08 | 57.55M shares derived: average of 3 quarters · filed 2015-02-13 | 56.05M shares derived: average of 4 quarters · filed 2015-02-13 |
| 2013-03-31 | 59.17M shares 10-K · filed 2015-02-13 | 55.50M shares derived: average of 2 quarters · filed 2015-02-13 | 54.18M shares derived: average of 3 quarters · filed 2015-02-13 | 53.45M shares derived: average of 4 quarters · filed 2015-02-13 |
| 2012-12-31 | 51.82M shares 10-K · filed 2014-02-20 | 51.68M shares derived: average of 2 quarters · filed 2014-02-20 | 51.55M shares derived: average of 3 quarters · filed 2014-02-20 | 50.29M shares 10-K · filed 2015-02-13 |
| 2012-09-30 | 51.54M shares 10-K · filed 2014-02-20 | 51.41M shares derived: average of 2 quarters · filed 2014-02-20 | 49.77M shares 10-Q · filed 2013-11-07 | 47.94M shares derived: average of 4 quarters · filed 2014-02-20 |
| 2012-06-30 | 51.28M shares 10-K · filed 2014-02-20 | 48.88M shares 10-Q · filed 2013-08-09 | 46.73M shares derived: average of 3 quarters · filed 2014-02-20 | 45.71M shares derived: average of 4 quarters · filed 2014-02-20 |
| 2012-03-31 | 46.21M shares 10-K · filed 2014-02-20 | 44.46M shares derived: average of 2 quarters · filed 2014-02-20 | 43.86M shares derived: average of 3 quarters · filed 2014-02-20 | 43.49M shares derived: average of 4 quarters · filed 2014-02-20 |
| 2011-12-31 | 42.72M shares 10-K · filed 2013-02-19 | 42.68M shares derived: average of 2 quarters · filed 2013-02-19 | 42.58M shares derived: average of 3 quarters · filed 2013-02-19 | 42.41M shares 10-K · filed 2014-02-20 |
| 2011-09-30 | 42.65M shares 10-K · filed 2013-02-19 | 42.52M shares derived: average of 2 quarters · filed 2013-02-19 | 42.39M shares 10-Q · filed 2012-11-05 | |
| 2011-06-30 | 42.38M shares 10-K · filed 2013-02-19 | 42.37M shares 10-Q · filed 2012-08-08 | ||
| 2011-03-31 | 42.34M shares 10-K · filed 2013-02-19 | |||
| 2010-12-31 | 42.04M shares 10-K · filed 2013-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |